The AHNS acknowledges a generous educational grant in support of this educational webinar series from Intuitive Surgical
AHNS TORS Webinar Series
February 22, 2023
Additional Information coming soon!
Past AHNS Webinar (click the banner to access the recording)
Presented on November 16, 2022, at 7:00 PM Eastern USA Time
Robotic H&N Surgery has transformed the treatment landscape of oropharyngeal cancer. In 2019, a single-port (SP) robotic surgical system supplanted rigid-arm first generation systems. While offering new capabilities, there is a learning curve associated with this new area of robotics. In this webinar, we discuss a few of the critical news skills to master, as well as controversies and consensus around the SP.
Chris Holsinger, MD, FACS – Stanford University
Kathryn (Katie) Van Abel, MD – Mayo Clinic
Ryan Li, MD, MBA – Oregon Health & Science University
Ryan Jackson, MD – Washington University School of Medicine
Oluwafunmilola T. Okuyemi, MD, MSCI, FACS – University of Nevada, Las Vegas
Brittany Barber, MD, MSc, FRCSC – University of Washington
Baran Sumer, MD – UT Southwestern Medical Center
Webinar 1 – The Pandemic Papers: TORS Research and Practice Innovation, 2021-2022
Delivered on Wednesday, April 20th 7pm ET/6pm CT/5pm MT/4pm PT
|Moderators:||Giovana Thomas, MD, University of Miami|
|Karthik Rajasekaran, MD, University of Pennsylvania|
Katherine Hutcheson, MD, University of Texas – MD Anderson Cancer Center
Kathryn Van Abel, MD, Mayo Clinic
Ryan Orosco, MD, University of California – San Diego
Elizabeth Anne Nicolli, MD, University of Miami
Erin Rachel Cohen, MD, University of Pennsylvania
Description: COVID may have slowed down some of our clinical output, but it most certainly has not decreased the academic output! This interactive session will highlight and discuss some of the studies published over the past 2 years, which would have ordinarily been presented at our national meetings.
- Highlight some of the main manuscripts published between 2020-2021 as it relates to Trans Oral Robotic Surgery (TORS) and oropharyngeal carcinoma
- Review the take home points from each of these manuscripts
- Discuss opportunities for future innovation and collaboration across institutions
Webinar 1 – Patient Selection & Complications
|Moderators:||Neil Gross, MD, FACS; MD Anderson Cancer Center|
|Barry Wenig, MD; University of Illinois at Chicago|
|Panelists:||Meghan Turner, MD; West Virginia University Medical Center|
|David Cognetti, MD; Thomas Jefferson University Hospital|
|Mihir Patel, MD; Emory University Hospital Midtown|
Description: Patient selection is key to the successful application of TORS. Join this expert panel discussion to explore common approaches to selecting patients for TORS as well as techniques for avoiding complications.
|Moderators:||Katie Van Abel, MD; Mayo Clinic|
|Chris Holsinger, MD; Stanford University|
|Panelists:||Guiseppe Spriano, MD; H&N Surgery, Humanitas University, Milano, IT|
|Mererid Evans, MD; Oncology; University of Cardiff, Wales, UK|
|Joaquin Garcia, MD; Pathology The Mayo Clinic, MN|
|Jason Chan, MD; The Chinese University of Hong Kong|
Description: Controversies in managing patients with oropharyngeal cancer with TORS and neck dissection are discussed in this multidisciplinary panel. What are pre-operative indications for the ideal TORS candidate? Which pre-treatment factors should nudge patients toward chemoradiation? Are there objective criteria to advise patients? In particular, the panel will discuss the impact of extranodal extension and margin assessment on post-operative adjuvant therapy.
|Moderators:||Uma Duvvuri, MD, PhD – University of Pittsburgh Medical Center|
|Ranee Mehra, MD; Oncology; University of Maryland Medical Center|
|Panelists:||Robert Ferris, MD, PhD – UPMC Hillman Cancer Center|
|Daniel C. Ma, MD – Mayo Clinic|
|David Palma, MD – London Health Sciences Centre|
Description: The incidence of HPV-associated oropharyngeal cancer is rapidly increasing. Given the oncologic outcomes for this disease, there is great interest in rationally de-escalating treatment for some patients. The panelists on this webinar will present current data from clinical trials that describe options for treatment de-escalation. The panel discussion will present real world cases, and provide the audience with an opportunity to understand the application and limitations of these data in the management of patients with oropharyngeal cancer.
|Moderators:||Jeremy Richmon, MD, FACS; Massachusetts Eye & Ear|
|Panelists:||Daniel Clayburgh, MD, PhD; Oregon Health & Science University|
|Andrew J. Holcomb, MD; Nebraska Methodist Medical Center / Creighton University|
|Allison Hollman, MS, CCC-SLP; Mass General Cancer Center|
|Carol M Lewis, MD, MPH; UT MD Anderson Cancer Center|
Description: Despite transoral robotic surgery (TORS) being a well-accepted tool in the management of patients with oropharyngeal cancer, perioperative care pathways vary considerably from one institution to another. Growing utilization of enhanced recovery after surgery (ERAS) protocols have yielded compelling data across multiple disciplines, albeit not yet for TORS. In this panel, we will discuss the current landscape of perioperative care pathways for the TORS patient including pre-operative counseling and education, management of anticoagulation, ERAS protocols, pain control, speech language pathology involvement and swallow initiation.